Clinical Trial Update: A Study Comparing SB5 to Humira® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing SB5 to Humira in patients with moderate to severe rheumatoid arthritis who are on methotrexate, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Humira (adalimumab)
• SB5 (adalimumab biosimilar)

Snippet

Sponsor: Samsung Bioepis Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2017-01-19